Oral Metformin Inhibits Choroidal Neovascularization by Modulating the Gut-Retina Axis.

Publication Year: 2023

DOI:
10.1167/iovs.64.15.21

PMCID:
PMC10732090

PMID:
38108689

Journal Information

Full Title: Invest Ophthalmol Vis Sci

Abbreviation: Invest Ophthalmol Vis Sci

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Ophthalmology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure: J.Y. Zhang, None; J. Xiao, None; B. Xie, None; H. Barba, None; M. Boachie-Mensah, None; R.N. Shah, None; U. Nadeem, None; M. Spedale, None; N. Dylla, None; H. Lin, None; A.M. Sidebottom, None; M. D'Souza, None; B. Theriault, None; D. Sulakhe, None; E.B. Chang, None; D. Skondra, None"

Evidence found in paper:

"Supported by Genentech AMD Research Fellowship “Common antidiabetic drug metformin prevents AMD by reshaping the gut microbiome” (D. Skondra), Institute for Translational Medicine (D. Skondra), BrightFocus Foundation “Role of high fat diet and gut microbiome in macular degeneration” (D. Skondra, M2018042), NIDDK P30 (E.B.C., DK42086), The University of Chicago Women's Board (D. Skondra), FORE-I Foundation (D. Skondra), and the Illinois Society for the Prevention of Blindness (D. Skondra, FP067271-01-PR)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025